Skip to content
10-K

Annual Report

iBio, Inc. IBIO

0001558370-25-011888

← back to feed
Filed
Sep 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Sep 4, 2025 19.65M sh
Shares Diluted FY 2025 · Jun 30, 2025 10.5M sh
Capex FY 2025 · Jun 30, 2025 $16K
Operating Cash Flow FY 2025 · Jun 30, 2025 −$15.3M
Cash And Equivalents FY 2025 · Jun 30, 2025 $8.58M
Stockholders Equity FY 2025 · Jun 30, 2025 $14.88M
Current Liabilities FY 2025 · Jun 30, 2025 $6.11M
Total Liabilities FY 2025 · Jun 30, 2025 $8.31M
Current Assets FY 2025 · Jun 30, 2025 $9.72M
Total Assets FY 2025 · Jun 30, 2025 $23.19M
Eps Diluted FY 2025 · Jun 30, 2025 −$1.75
Eps Basic FY 2025 · Jun 30, 2025 −$1.75
Sga Expense FY 2025 · Jun 30, 2025 $10.69M
Rd Expense FY 2025 · Jun 30, 2025 $8.31M
Net Income FY 2025 · Jun 30, 2025 −$18.38M
Operating Income FY 2025 · Jun 30, 2025 −$18.6M
Revenue FY 2025 · Jun 30, 2025 $400K